Marye Wahl v. General Electric Co.

786 F.3d 491, 2015 FED App. 0100P, 2015 U.S. App. LEXIS 8477, 2015 WL 2445066
CourtCourt of Appeals for the Sixth Circuit
DecidedMay 22, 2015
Docket13-6622
StatusPublished
Cited by26 cases

This text of 786 F.3d 491 (Marye Wahl v. General Electric Co.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Sixth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Marye Wahl v. General Electric Co., 786 F.3d 491, 2015 FED App. 0100P, 2015 U.S. App. LEXIS 8477, 2015 WL 2445066 (6th Cir. 2015).

Opinion

OPINION

BOGGS, Circuit Judge.

Plaintiff-Appellant Marye Wahl appeals the district court’s grant of summary judgment to Defendant-Appellee General Electric (GE) in her personal-injury action arising out of the development of a rare and serious disease following the administration of one of GE’s drugs. The district court granted the defendant’s motion for summary judgment based on Tennessee’s statute of repose. For the reasons below, we affirm the district court’s grant of summary judgment.

I

Defendant-Appellee General Electric manufactures Omnisean, a gadolinium-based contrast agent approved by the FDA. The administration of Omniscan has *493 been associated in some patients with the development of nephrogenic systemic fibrosis (NSF). NSF, “a progressive fibrotic disease affecting the tissues and organs with no known cure,” In re Gadolinium-Based Contrast Agents Products Liab. Litig., MDL No. 1909 2010 WL 1796334, at *1 (N.D.Ohio May 4, 2010), op. mod. on reconsideration, 2010 WL 5173568 (N.D.Ohio June 18, 2010), is a rare and deadly condition that leads to the hardening (fibrosis) of the kidneys and is usually seen in patients with severe kidney disease following exposure to gadolinium.

Omniscan was administered to Wahl for two MRIs she received in Nashville, Tennessee, in May and November 2006. In May 2007, about one year after Wahl’s first administration of Omniscan, she displayed the first symptoms of NSF. She was officially diagnosed with NSF in October 2010.

Wahl is a resident of and was treated and diagnosed in Tennessee. However, the Judicial Panel on Multidistrict Litigation consolidated all pre-trial litigation of Omniscan-related cases in the United States District Court for the Northern District of Ohio. In re: Gadolinium Contrast Dyes Prods. Liab. Litig., 536 F.Supp.2d 1380, 1382 (J.P.M.L.2008) (MDL 1909). Although plaintiffs usually file complaints destined for an MDL-designated district in their home district and allow the judge to transfer their case for pre-trial litigation, this MDL panel issued a “Direct Filing Order” that permitted plaintiffs to avoid the seemingly inefficient step of filing-and-transfer required in the absence of such an order. Accordingly, in May 2011, Wahl filed a complaint in the Northern District of Ohio alleging injury from the administration of Omniscan to her. With the agreement of both Wahl and GE, the MDL judge in Ohio transferred the case almost two years later, in April 2013, to the United States District Court for the Middle District of Tennessee, “the district court of proper venue.”

Shortly after the transfer to the Middle District of Tennessee, GE moved for summary judgment, arguing that, since Wahl received her MRIs in 2006, and since all Omniscan doses produced from 2004 to 2006 were marked with expiration dates ■two years after manufacture, the Omnis-can administered to her must have expired no later than 2008. GE further argued that the Tennessee Products Liability Act’s (TPLA) statute of repose, which requires all suits to be instituted within one year of the expiration date appearing on a product’s packaging, barred Wahl’s suit because all of her claims expired, at the latest, on November 1, 2009 — almost two years before she filed her complaint. Wahl argued that, for choice-of-law reasons, the Tennessee statute did not apply. The district court granted GE’s motion. In its opinion, it applied Tennessee choice-of-law rules, which required the application of Tennessee substantive law, including the statute of repose. Wahl timely appealed.

II

We review the district court’s determination regarding choice of law de novo. See Salve Regina Coll. v. Russell, 499 U.S. 225, 231, 111 S.Ct. 1217, 113 L.Ed.2d 190 (1991); Charash v. Oberlin Coll., 14 F.3d 291, 296 (6th Cir.1994).

We also review the district court’s grant of summary judgment de novo. See Rannals v. Diamond Jo Casino, 265 F.3d 442, 447 (6th Cir.2001). Summary judgment should be awarded only when “there is no genuine issue of material fact and the moving party is entitled to a judgment as a matter of law.” Fed. R. Civ. P. 56(a). In deciding whether there exists a genuine issue of material fact, the court must view *494 all evidence in the light most favorable to the nonmoving party. See Matsushita Elec. Indus. Co. v. Zenith Radio Corp., 475 U.S. 574, 587, 106 S.Ct. 1348, 89 L.Ed.2d 538 (1986).

Ill

On appeal, Wahl advances three arguments. First, she argues that Ohio choice-of-law principles must guide the determination of substantive law in this case because federal law requires the use of the choice-of-law principles of the state of the transferor court. Wahl claims that, because she availed herself of the procedural option of filing directly with the MDL court in Ohio, once the MDL court subsequently transferred the case to Tennessee the MDL court is the transferor court.

Second, Wahl argues that, under Ohio choice-of-law principles, the Tennessee statute 'of repose, which effectively extinguished her vested cause of action before she could discover it, could not be applied because it violates Ohio public policy, as articulated in the Ohio Constitution’s Right to Remedy Clause.

Finally, Wahl argues that New Jersey substantive law must be applied under the choice-of-law rules.of either Tennessee or Ohio and that the motion for summary judgment would be defeated because there is no statute of repose under New Jersey law. The Restatement (Second) of Conflict of Laws informs the relevant law both of Ohio and of Tennessee.

We affirm the judgment of the district court because the choice-of-law rules of Tennessee are the correct rules to govern this case. In addition, under both the Tennessee and Ohio choice-of-law regimes, Tennessee substantive law, including its statute of repose, applies to this case, despite the Right to Remedy Clause in the Ohio Constitution. New Jersey law does not apply.

A

According to the typical rule, when a diversity ease is transferred from one federal district court to another, substantive law governing the jurisdiction of the transferor court controls. This ordinary rule appears strict and inflexible. But it does not apply to cases of direct-filed, later-transferred MDL suits such as the present case. The United States District Court for the Northern District of Ohio was not a transferor court, as defined by the doctrine: At the conclusion of pretrial litigation, Wahl and GE jointly requested transfer to the Middle District of Tennessee where, but for the MDL, Wahl would have filed in the first place. Accordingly, Tennessee choice-of-law rules apply in this case.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Stinson v. Davol, Inc.
S.D. Ohio, 2023
Victoria Looper v. Cook Incorporated
20 F.4th 387 (Seventh Circuit, 2021)
John Petitta v. 3M Company
Eighth Circuit, 2021
Jones v. Ethicon, Inc.
S.D. Georgia, 2021
Heather Wanke v. Invasix Inc.
M.D. Tennessee, 2021
Jones v. Invasix Inc.
M.D. Tennessee, 2021
Kines v. Ford Motor Company
W.D. Tennessee, 2020
Bernard v. Ethicon, Inc.
E.D. Pennsylvania, 2020
Rose v. Bersa
S.D. Ohio, 2020
Dalton v. C R Bard Inc
N.D. Texas, 2020

Cite This Page — Counsel Stack

Bluebook (online)
786 F.3d 491, 2015 FED App. 0100P, 2015 U.S. App. LEXIS 8477, 2015 WL 2445066, Counsel Stack Legal Research, https://law.counselstack.com/opinion/marye-wahl-v-general-electric-co-ca6-2015.